Main navigation

About Us
- Partners
Team
Senior Advisors
Portfolio
News
Events
Contact

Investing in Life Science Innovation

TVM Capital Life Science is a group of independent investment advisories and fund managers for Venture Capital funds, investing into innovative biotech, pharmaceutical, and medtech companies in Europe, Canada the USA and Asia, with teams based in Munich and Montreal.

Learn more

Home
About Us
Team
Senior Advisors
Portfolio
News
Events
Contact

Main Content

Attraktiv für Investoren! Individualisierte Medizin ist schon lange grundlegend für die erfolgreiche Behandlung von Patienten

May 17, 2017

NOXXON PHARMA secures a private placement of 1 million Euro and additional financing of up to 10 million Euro through convertible notes with share subscription warrants attached to finance further clinical development of NOX-A12

May 9, 2017

Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid

March 23, 2017

Footer

About Us

We are creating sustainable value – for patients, the pharmaceutical industry and our investors. Since 1984, TVM Capital Life Science has invested in more than 130 life science companies in Europe, Canada and the United States, currently managing in excess of €900 million from more than 50 investors.

Our Team

TVM Capital Life Science operates with an integrated team from its offices in Montreal and Munich. Our mission is to invest in the development of exciting life science products and the growth of substantial companies in the field that are or aspire to be innovative leaders in their market segment.

Offices

TVM Capital GmbH
Munich, Germany

TVM Life Science Management GmbH
Munich, Germany

TVM Life Science Management Inc.
Montreal, Westmount, Canada

TVM Capital Group
TVM Capital Healthcare
TVM Capital Life Science